- Home
- HUIZ vs LSTA Comparison
HUIZ vs LSTA Comparison
Compare HUIZ & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- LSTA
- Stock Information
- Founded
- HUIZ 2006
- LSTA 1980
- Country
- HUIZ China
- LSTA United States
- Employees
- HUIZ N/A
- LSTA N/A
- Industry
- HUIZ Specialty Insurers
- LSTA Misc Health and Biotechnology Services
- Sector
- HUIZ Finance
- LSTA Health Care
- Exchange
- HUIZ Nasdaq
- LSTA Nasdaq
- Market Cap
- HUIZ 32.0M
- LSTA 31.2M
- IPO Year
- HUIZ 2020
- LSTA N/A
- Fundamental
- Price
- HUIZ $3.05
- LSTA $2.75
- Analyst Decision
- HUIZ
- LSTA Strong Buy
- Analyst Count
- HUIZ 0
- LSTA 1
- Target Price
- HUIZ N/A
- LSTA $15.00
- AVG Volume (30 Days)
- HUIZ 39.7K
- LSTA 77.2K
- Earning Date
- HUIZ 03-19-2025
- LSTA 02-27-2025
- Dividend Yield
- HUIZ N/A
- LSTA N/A
- EPS Growth
- HUIZ N/A
- LSTA N/A
- EPS
- HUIZ 0.29
- LSTA N/A
- Revenue
- HUIZ $170,927,079.00
- LSTA N/A
- Revenue This Year
- HUIZ N/A
- LSTA N/A
- Revenue Next Year
- HUIZ $10.46
- LSTA N/A
- P/E Ratio
- HUIZ $10.82
- LSTA N/A
- Revenue Growth
- HUIZ N/A
- LSTA N/A
- 52 Week Low
- HUIZ $2.15
- LSTA $2.19
- 52 Week High
- HUIZ $10.58
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- HUIZ 47.47
- LSTA 37.40
- Support Level
- HUIZ $2.86
- LSTA $3.51
- Resistance Level
- HUIZ $3.19
- LSTA $4.11
- Average True Range (ATR)
- HUIZ 0.33
- LSTA 0.37
- MACD
- HUIZ -0.01
- LSTA -0.05
- Stochastic Oscillator
- HUIZ 35.29
- LSTA 21.62
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.